Skip to main content
OpenTrials
Completed

NCT Number: NCT00964613

Pars Plana Surgical Capsulotomy for Posterior Capsular Opacification

Cataract is a leading cause of Global blindness. After cataract surgery nearly half of the people become blind due to posterior capsular opacification. The only solution for this problem is LASER capsulotomy. Laser machine is not available in remote areas especially in underdeveloped countries. The solution of this problem is surgical capsulotomy which can be performed any where.

Completed

Looking for future studies?

Notify Me

Key information

About this study

posterior capsular opacification is treated by YAG laser capsulotomy. this require sophisticated technology ans specific environment which is not possible in underdeveloped countries. we describe a method in which posterior capsular opacification could be managed by using only a 27 Gauge needle through pars plana. opacified posterior capsule is under tension that is why a small puncture results in a large central opening

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with Posterior capsular opacification
  • Both Sexes
  • All ages

Exclusion criteria

  • Retinal disease
  • Uncontrolled Glaucoma
  • Corneal opacity

Sponsors and collaborators

Lead sponsor

Dow University of Health Sciences

Other

Collaborators

  • Pakistan Ministry of Health

Registry information

Acronym: Capsulotomy

Important dates

Study start
2008
Primary completion
2009
Study completion
2009
First posted
Aug 25, 2009
Registry last updated
Aug 7, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.